DHCR24 overexpression is involved in lipid metabolic reprogramming to drive cervical cancer malignant progression and is associated with immune microenvironment
Abstract Objective Lipid metabolic reprogramming enables tumor cells to acquire malignant phenotypes, including enhanced proliferative capacity, migratory potential, and invasive properties. In cervical cancer, the precise pathobiological roles and molecular mechanisms of DHCR24 remain unclear. Meth...
שמור ב:
| Principais autores: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2025-08-01
|
| סדרה: | BMC Cancer |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12885-025-14663-2 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
